OR

348.75

+2%↑

B.US

37.6

+1.4%↑

ASM

669.4

+6.42%↑

IAG.ES

4.17

+8.03%↑

UPM.FI

25.27

+2.89%↑

OR

348.75

+2%↑

B.US

37.6

+1.4%↑

ASM

669.4

+6.42%↑

IAG.ES

4.17

+8.03%↑

UPM.FI

25.27

+2.89%↑

OR

348.75

+2%↑

B.US

37.6

+1.4%↑

ASM

669.4

+6.42%↑

IAG.ES

4.17

+8.03%↑

UPM.FI

25.27

+2.89%↑

OR

348.75

+2%↑

B.US

37.6

+1.4%↑

ASM

669.4

+6.42%↑

IAG.ES

4.17

+8.03%↑

UPM.FI

25.27

+2.89%↑

OR

348.75

+2%↑

B.US

37.6

+1.4%↑

ASM

669.4

+6.42%↑

IAG.ES

4.17

+8.03%↑

UPM.FI

25.27

+2.89%↑

Search

KWS Saat SE

Deschisă

SectorMateriale de bază

65.9 1.38

Rezumat

Modificarea prețului

24h

Curent

Minim

64.5

Maxim

67.1

Indicatori cheie

By Trading Economics

Venit

-54M

-64M

Vânzări

-45M

183M

P/E

Medie Sector

14.112

34.302

EPS

-1.636

Randament dividend

1.67

Marjă de profit

-34.844

Angajați

4,979

EBITDA

-81M

-76M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+23.92% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

1.67%

2.86%

Următoarele câștiguri

12 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

215M

2.4B

Deschiderea anterioară

64.52

Închiderea anterioară

65.9

Sentimentul știrilor

By Acuity

50%

50%

80 / 151 Clasament în Basic materials

Scor tehnic

By Trading Central

Încredere

Strong Bullish Evidence

KWS Saat SE Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

23 mar. 2026, 23:47 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23 mar. 2026, 22:55 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23 mar. 2026, 21:51 UTC

Achiziții, Fuziuni, Preluări

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23 mar. 2026, 23:59 UTC

Market Talk

Global Equities Roundup: Market Talk

23 mar. 2026, 23:59 UTC

Market Talk

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23 mar. 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23 mar. 2026, 23:37 UTC

Market Talk

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23 mar. 2026, 22:42 UTC

Market Talk
Evenimente importante

Global Equities Roundup: Market Talk

23 mar. 2026, 22:42 UTC

Market Talk
Evenimente importante

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23 mar. 2026, 22:40 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23 mar. 2026, 22:23 UTC

Market Talk

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23 mar. 2026, 22:22 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23 mar. 2026, 22:21 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23 mar. 2026, 22:21 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23 mar. 2026, 22:20 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23 mar. 2026, 22:20 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23 mar. 2026, 22:19 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23 mar. 2026, 22:19 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23 mar. 2026, 22:18 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23 mar. 2026, 22:15 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23 mar. 2026, 22:08 UTC

Market Talk

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23 mar. 2026, 21:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

23 mar. 2026, 21:42 UTC

Market Talk

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23 mar. 2026, 21:32 UTC

Câștiguri

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23 mar. 2026, 21:32 UTC

Câștiguri

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23 mar. 2026, 21:32 UTC

Câștiguri

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23 mar. 2026, 21:10 UTC

Evenimente importante

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23 mar. 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

23 mar. 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

23 mar. 2026, 20:50 UTC

Market Talk
Câștiguri
Evenimente importante

Basic Materials Roundup: Market Talk

Comparație

Modificare preț

KWS Saat SE Așteptări

Obiectiv de preț

By TipRanks

23.92% sus

Prognoză pe 12 luni

Medie 81.17 EUR  23.92%

Maxim 91.5 EUR

Minim 74 EUR

În baza a 4 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruKWS Saat SE - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

4 ratings

3

Cumpărare

1

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

54.8 / 57.4Suport & Rezistență

Termen scurt

Strong Bullish Evidence

Termen mediu

Weak Bullish Evidence

Termen lung

Bearish Evidence

Sentiment

By Acuity

80 / 151 Clasament în Materiale de bază

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre KWS Saat SE

KWS SAAT SE & Co. KGaA breeds, produces, and distributes seeds for agriculture. It operates through four segments: Corn, Sugarbeet, Cereals, and Vegetables. The Corn segment breeds, produces, and distributes seed for corn, soybeans, and sunflowers. The Sugarbeet segment engages in the development, breeding, production, and development of diploid hybrid potatoes and sugar beet seeds. The Cereals segment breeds, produces, and distributes seeds for rye, wheat, barley, and oilseed rape. This segment also offers other crops, including peas, catch crops, and oats. The Vegetables segment engages in the breeding, production, and distribution of seeds for spinach, beans, Swiss chard, red beet, and tomatoes. The company was formerly known as KWS SAAT SE and changed its name to KWS SAAT SE & Co. KGaA in July 2019. KWS SAAT SE & Co. KGaA was founded in 1856 and is headquartered in Einbeck, Germany.
help-icon Live chat